IDBI Member Leads SLU’s COVID-19 Treatment Trial

Clinical Trial for experimental drug remdesivir, under the direction of IDBI member Dr.Sarah George, shows promising results for the reduction of recovery time in COVID-19 patients. Patients receiving remdesivir treatment decreased recovery time from 15 to 11 days and mortality rates dropped from 11.6% to 8%.

More information can be found here.

Sarah George, M.D., is an associate professor of infectious diseases at Saint Louis University. Photo by Ellen Hutti.